O
OrbiMed’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145M | Hold |
8,288,510
| – | – | 3.61% | 7 |
|
|
2025
Q1 | $104M | Hold |
8,288,510
| – | – | 2.49% | 11 |
|
|
2024
Q4 | $87.4M | Hold |
8,288,510
| – | – | 1.8% | 16 |
|
|
2024
Q3 | $120M | Sell |
8,288,510
-952,377
| -10% | -$13.8M | 2.18% | 11 |
|
|
2024
Q2 | $78.6M | Hold |
9,240,887
| – | – | 1.55% | 17 |
|
|
2024
Q1 | $94.4M | Hold |
9,240,887
| – | – | 1.73% | 15 |
|
|
2023
Q4 | $50.6M | Hold |
9,240,887
| – | – | 1.01% | 34 |
|
|
2023
Q3 | $34.9M | Buy |
9,240,887
+500,000
| +6% | +$1.89M | 0.74% | 50 |
|
|
2023
Q2 | $58.6M | Hold |
8,740,887
| – | – | 1.06% | 36 |
|
|
2023
Q1 | $56.9M | Hold |
8,740,887
| – | – | 1.12% | 29 |
|
|
2022
Q4 | $74.6M | Hold |
8,740,887
| – | – | 1.43% | 24 |
|
|
2022
Q3 | $46.2K | Hold |
8,740,887
| – | – | 0.86% | 44 |
|
|
2022
Q2 | $37.1K | Hold |
8,740,887
| – | – | 0.67% | 47 |
|
|
2022
Q1 | $30.7M | Hold |
8,740,887
| – | – | 0.5% | 53 |
|
|
2021
Q4 | $58.2M | Hold |
8,740,887
| – | – | 0.75% | 44 |
|
|
2021
Q3 | $87.2M | Hold |
8,740,887
| – | – | 0.96% | 30 |
|
|
2021
Q2 | $270M | Hold |
8,740,887
| – | – | 2.73% | 8 |
|
|
2021
Q1 | $381M | Hold |
8,740,887
| – | – | 3.57% | 5 |
|
|
2020
Q4 | $405M | Buy |
+8,740,887
| New | +$405M | 3.54% | 4 |
|